Nutrien Reports Strong 2025 Earnings, Boosts Dividend, and Launches New Share Buyback Program

summarizeSummary

Nutrien Ltd. filed its annual report, detailing robust 2025 financial results with a significant increase in net earnings and adjusted EBITDA, alongside an increased quarterly dividend and a new 5% share repurchase program.

check_boxKey Events

• Strong 2025 Financial Performance

  Reported net earnings of $2.297 billion and adjusted EBITDA of $6.046 billion for 2025, significantly up from 2024 figures of $700 million and $5.355 billion, respectively.

• Increased Quarterly Dividend

  The Board declared an increased quarterly dividend of $0.55 per share, payable on April 16, 2026, to shareholders of record on March 31, 2026.

• New Share Repurchase Program Authorized

  A 2026 Normal Course Issuer Bid was approved to repurchase up to 24,057,066 common shares (representing 5% of outstanding shares), commencing March 3, 2026.

• Strategic Portfolio Optimization Continues

  The company is continuing its strategic review of the Phosphate business and assessing options for its Trinidad operations, following the controlled shutdown of the Trinidad Nitrogen facility in Q4 2025 due to port access and gas supply issues.

auto_awesomeAnalysis

This 40-F filing provides the comprehensive, audited financial results for fiscal year 2025, confirming the strong performance previously indicated in preliminary announcements. The substantial increase in net earnings and adjusted EBITDA demonstrates operational strength. The Board's approval of a new share repurchase program for up to 5% of outstanding shares, coupled with a modest dividend increase, signals confidence in future cash flow and a commitment to returning capital to shareholders. The ongoing strategic review of the Phosphate business and Trinidad operations, following the controlled shutdown of the Trinidad facility, indicates a continued focus on portfolio optimization. The company also provided 2026 guidance for its key segments, reinforcing its outlook.